Repligen corporation

Repligen is an American company repligen corporation to the development and production of materials used in the manufacture of biological drugs. BeforeRepligen maintained dual capabilities in developing pharmaceutical therapeutics drug discovery and development and the development of materials supporting biological drug manufacture bioprocessing business. Repligen employs a direct sales model to users of its products in the United States, with some sales through intermediaries in "certain foreign markets". As a consequence of current operations, about one-third each of revenue and cost and expenses are denominated in Swedish krona currency, repligen corporation, the remaining two-thirds repligen corporation in United States dollars ; this presents a risk to the business based on unpredictable fluctuations in currency exchange rates, repligen corporation.

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands.

Repligen corporation

Overcome common challenges. Push the boundaries of what's possible. Maximize productivity at every step. Simplify complex workflows. Accelerate new modalities. Leverage technology breakthroughs and expert engineering. See how it works. Repligen is revolutionizing how modern chromatography is performed. The result? Unprecedented recovery and operational efficiencies even with the most complex modalities.

Welcome FlexBiosys! August

Powered by. Repligen Corp Repligen is a life science company that develops and commercializes bioprocessing technologies for the manufacturing of biological drugs. Its products include upstream and downstream filtration, chromatography products, fluid management, cell culture supplements, ligands, and operating room disposables. The company also provides solutions to overcome the development and production of modalities into a new class of drugs. Its services comprise hands-on-process and implementation consultation services.

Tony J. The business complements what we have already in place at our Rancho Dominguez site and establishes a world-class center of excellence in Europe to meet the accelerating demand for hollow fiber products and to serve our rapidly expanding global customer base. We continue to increase capacity with the extension of our production site in Castanet-Tolosan, south of Toulouse, and we look forward to working together with Repligen to further penetrate our core markets. Jean-Michel Espenan and Franc Saux will stay on with the company in their current respective roles of President and Technical Director. Additional financial details were not disclosed. About Repligen Corporation Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. We are inspiring advances in bioprocessing for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations CDMOs worldwide.

Repligen corporation

With its stock down 4. Particularly, we will be paying attention to Repligen's ROE today. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. Check out our latest analysis for Repligen. The 'return' is the amount earned after tax over the last twelve months.

Shorts auto scroll

Public company. The reason given is: hasn't been materially touched since View Repligen Corp financials. He used to be the John D. All rights reserved. Currency in USD. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk. Read Edit View history. Accelerate new modalities. Repligen's company headquarters are housed together with its manufacturing facility in Waltham, Massachusetts. Download as PDF Printable version. Watch webinar. News

Tony J. Strategically, our three acquisitions of Polymem, Avitide and BioFlex position us well to continue to drive above market growth in Our financial guidance for the fiscal year is based on expectations for our existing business and includes the financial impact of our acquisitions of BioFlex Solutions which closed on December 16, , Avitide Inc.

Read Edit View history. See how it works. Tools Tools. News Empowering a new generation of biologics Repligen provides technology breakthroughs and scalable hardware, software and consumables workflow solutions for the development and manufacture of plasmid DNA, viral vectors, mRNA and new modalities such as whole cells, cultivated meat. About Our Ads Sitemap. Repligen is revolutionizing how modern chromatography is performed. Repligen acquires FlexBiosys Inc. Subscribe now. The reason given is: hasn't been materially touched since Repligen's company headquarters are housed together with its manufacturing facility in Waltham, Massachusetts. Have you found what you were looking for? Push the boundaries of what's possible. Who We Serve Build your customized intelligence tool.